The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hormosan brand of imidapril hydrochloride Drug Master File in Japan (Hormosan brand of imidapril hydrochloride JDMF) empowers Hormosan brand of imidapril hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hormosan brand of imidapril hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Hormosan brand of imidapril hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hormosan brand of imidapril hydrochloride suppliers with JDMF on PharmaCompass.